MAPT and Alzheimer disease: In current AD drug research, many targets or strategies are considered, such as preventing Aβ accumulation or tau phosphorylation, inhibition of secretase activity that directly modulates Aβ generation, OS, neuroinflammation, as well as mitochondrial damage (Tundis et al., 2018).